Serum IL-23, E-selectin and sICAM levels in non-small cell lung cancer patients before and after radiotherapy.

Published in: The Journal of international medical research (2021)

Serum IL-23, E-selectin and sICAM levels were elevated in NSCLC patients. While our results demonstrate the prognostic value of these parameters, further molecular studies of NSCLC patients are warranted.

Keyphrases

end stage renal disease
ejection fraction
small cell lung cancer
newly diagnosed
chronic kidney disease
prognostic factors
early stage
radiation therapy
stem cells
cell therapy
patient reported